Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Despite the evidence, visual estimation continues to dominate the decision on intermediate lesions

Original title: Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions. Results of the International Survey on Interventional Strategy. Reference: Gabor G. Toth et al. CircCardiovascInterv. 2014. Epubahead of print.

 

Measurement of fractional flow reserve (FFR) is recommended by the guidelines and supported by evidence in intermediate lesions when not any proof of ischemia is available by noninvasive testing. The International Survey on Interventional Strategy evaluated the preferred approach of 495 experienced Interventional Cardiologists from several centers around the world who gave their opinion on a total of 4421 injuries. In the case of intermediate lesions by visual estimation they had the choice to define the strategy using the following; quantitative angiography, intravascular ultrasound (IVUS), optical coherence tomography (OCT) and fractional flow reserve (FFR). In 3158 lesions (71%), the decision was made relying merely on the angiographic appearance that in other hand was discordant in 47% with the measurement of FFR. 

FFR or other imaging modalities were required at 21% and 8% respectively. When comparing the 4 groups of participants according to their experience in FFR, it was observed that decisions based exclusively on angiography were less frequent as the FFR experience increased (77% versus 72% versus 69% versus 67%, respectively; p <0.001). As a result, the FFR was used more frequently (14% versus 19% versus 24% versus 28%, respectively; p <0.001) and the number of discordant decisions decreased (51% versus 49% versus 47% versus 43%, respectively; p <0.022).

Conclusion

These findings confirm that the visual estimation continues ruling the decision making in intermediate lesions indicating a worrying disengage between evidence, guidelines, and daily practice.

Editorial comment

Cost seems the simplest explanation that arises from the difference of what should be done and what is done in practice. Yet, all these interventionists had the possibility to select any of the methods available and they did not because they simply relied on angiography.

SOLACI

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...